BOSTON: A new proposed drug to combat Alzheimer’s disease, one of the leading causes of death, is now ready for trials to gauge its effectiveness. The drug known as T-817MA could not only slow but arrest the progress of the disease, researchers suggest.
T-817MA aims to actively alter the course of the disease to help people already suffering with dementia, making it different from current medications which are used to slow the early symptoms that come with the onset of Alzheimer’s, the researchers point out…